oxazoles has been researched along with Arthritis, Rheumatoid in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (43.75) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Cui, YM; Payne, CD; Sheng, XY; Wang, F; Zhang, X; Zhao, X | 1 |
Ha, H; Jin, WJ; Kim, B; Kim, HH; Lee, JH; Lee, ZH | 1 |
Andersson, IE; Batsalova, T; Dzhambazov, B; Edvinsson, L; Holmdahl, R; Kihlberg, J; Linusson, A | 1 |
Castañeda, S; Cutolo, M; Herrero-Beaumont, G; Roman-Blas, JA | 1 |
Cutolo, M | 1 |
Chelsky, D; Dorner, AJ; Follettie, MT; Harris, HA; Hayward, C; Kearney, P; Keith, JC; Paramithiotis, E; Pinard, M; Thibault, P; Wang, L | 1 |
Schorn, D | 1 |
West, GB | 1 |
Holford, NH; Mitchell, A; Muirhead, GJ; Williams, PE; York, A | 1 |
Haruta, J; Hashimoto, H; Imamura, K; Wakitani, K | 1 |
Dequeker, J; Jamar, R | 1 |
Ballard, IM; Gold, JA; Hubsher, JA; Walker, BR | 1 |
Bentley, J; Bird, HA; Helliwell, PS; Minty, S; Muirhead, GJ; Williams, PE; York, A | 1 |
Begany, AJ; Datko, SL; Dervinis, A; Gluckman, MI; Malis, JL; Rosenthale, ME; Shriver, DA | 1 |
Borrelli, F; Caprino, L; Falchetti, R | 1 |
Doury, P | 1 |
8 trial(s) available for oxazoles and Arthritis, Rheumatoid
Article | Year |
---|---|
Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study.
Topics: Administration, Oral; Adult; Area Under Curve; Arthritis, Rheumatoid; Asian People; Azetidines; Case-Control Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Half-Life; Healthy Volunteers; Humans; Male; Middle Aged; Oxazoles; Placebos; Purines; Pyrazoles; Safety; Sulfonamides | 2020 |
Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study.
Topics: Adult; Aged; Arthritis, Rheumatoid; Double-Blind Method; Estrogen Receptor beta; Female; Follow-Up Studies; Headache; Humans; Male; Middle Aged; Oxazoles; Treatment Outcome | 2010 |
Selective estrogen receptor agonism lacks clinical benefit in rheumatoid arthritis: comment on the article by van Vollenhoven et al.
Topics: Arthritis, Rheumatoid; Estrogen Receptor beta; Humans; Oxazoles; Severity of Illness Index; Treatment Outcome | 2010 |
A comparison between oxaprozin and naproxen in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Naproxen; Oxaprozin; Oxazoles; Propionates | 1981 |
Population pharmacodynamics of romazarit.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chromatography, High Pressure Liquid; Computer Simulation; Confidence Intervals; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Models, Chemical; Oxazoles; Radioimmunoassay | 1995 |
Oxaprozin versus aspirin in rheumatoid arthritis: a double-blind trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Oxazoles; Propionates | 1978 |
A multicentre double-blind comparison of oxaprozin aspirin therapy on rheumatoid arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Oxazoles; Propionates | 1979 |
A pharmacokinetic and tolerance study of romazarit in patients with rheumatoid arthritis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chromatography, High Pressure Liquid; Creatinine; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxazoles | 1992 |
8 other study(ies) available for oxazoles and Arthritis, Rheumatoid
Article | Year |
---|---|
JN-2, a C-X-C motif chemokine receptor 3 antagonist, ameliorates arthritis progression in an animal model.
Topics: Animals; Arthritis, Rheumatoid; Cell Movement; Chemokine CXCL10; Chemokines, CXC; Cytokines; Disease Models, Animal; Disease Progression; Male; Mice; Oxazoles; Transcription Factor RelA | 2018 |
Oxazole-modified glycopeptides that target arthritis-associated class II MHC A(q) and DR4 proteins.
Topics: Amides; Amino Acid Sequence; Animals; Arthritis, Rheumatoid; Collagen; Dipeptides; Drug Design; Glycopeptides; Histocompatibility Antigens Class II; Humans; Mice; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Oxazoles; Receptors, TNF-Related Apoptosis-Inducing Ligand; T-Lymphocytes | 2010 |
Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers; Blood Proteins; Estrogen Receptor beta; Gene Expression Profiling; Liver; Lymph Nodes; Male; Organ Specificity; Oxazoles; Random Allocation; Rats; Rats, Inbred Lew; RNA, Messenger; Spleen | 2006 |
Effects of levamisole and D-penicillamine on contact sensitivity to oxazolone in rats.
Topics: Anaphylaxis; Animals; Arthritis, Rheumatoid; Dermatitis, Contact; Female; Levamisole; Oxazoles; Oxazolone; Penicillamine; Rats; Rats, Inbred Strains | 1982 |
4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1)
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzenesulfonates; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Fluorine; Humans; Inhibitory Concentration 50; Isoenzymes; Membrane Proteins; Models, Chemical; Oxazoles; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Temperature | 2002 |
Anti-inflammatory properties of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin).
Topics: Airway Obstruction; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Bradykinin; Carrageenan; Dogs; Edema; Emulsions; Encephalomyelitis, Autoimmune, Experimental; Female; Fever; Freund's Adjuvant; Indazoles; Male; Molecular Weight; Mycobacterium; Oxazoles; Peptic Ulcer; Propionates; Rats; Sulfanilamides; Synovitis; Time Factors; Uric Acid; Yeasts | 1974 |
Pharmacological research on 4,5-diphenyl-2-bis(2-hydroxyethyl)-aminoxazol (Ditazol), a new synthetic oxazole derivative as an anti-inflammatory agent.
Topics: Administration, Oral; Administration, Topical; Adrenalectomy; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Temperature; Capillary Permeability; Edema; Ethanolamines; Female; Granuloma; Guanethidine; Hot Temperature; Male; Mice; Oxazoles; Phenylbutazone; Rats; Reserpine; Seizures | 1973 |
[Value in rheumatology of a combination of a muscle relaxant, an analgesic and a corticoid].
Topics: Adult; Aged; Analgesics; Arthritis, Rheumatoid; Catechols; Drug Synergism; Female; Humans; Male; Middle Aged; Oxazoles; Prednisolone; Rheumatic Diseases; Spondylitis, Ankylosing; Tranquilizing Agents | 1969 |